The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Graves Disease Treatment Market Research Report 2025
Synopsis
Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Although a number of disorders may result in hyperthyroidism, Graves' disease is a common cause. Thyroid hormones affect many body systems, so signs and symptoms of Graves' disease can be wide ranging.
Global Graves Disease Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Graves Disease Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Graves Disease Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
Merck & Co
Pfizer, Inc
AbbVie, Inc
Mylan N.V
Allergan, plc
Novartis AG
Apitope
Amgen INC.
Sun Pharmaceuticals Industries LTD
Immunovant Inc
Segment by Type
Anti-Thyroid Medication
Radioactive Iodine Therapy
Segment by Application
Hospitals Pharmacies
Retail Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Graves Disease Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Although a number of disorders may result in hyperthyroidism, Graves' disease is a common cause. Thyroid hormones affect many body systems, so signs and symptoms of Graves' disease can be wide ranging.
Global Graves Disease Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Graves Disease Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Graves Disease Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
Merck & Co
Pfizer, Inc
AbbVie, Inc
Mylan N.V
Allergan, plc
Novartis AG
Apitope
Amgen INC.
Sun Pharmaceuticals Industries LTD
Immunovant Inc
Segment by Type
Anti-Thyroid Medication
Radioactive Iodine Therapy
Segment by Application
Hospitals Pharmacies
Retail Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Graves Disease Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Graves Disease Treatment Market Overview
1.1 Product Overview and Scope of Graves Disease Treatment
1.2 Graves Disease Treatment Segment by Type
1.2.1 Global Graves Disease Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Anti-Thyroid Medication
1.2.3 Radioactive Iodine Therapy
1.3 Graves Disease Treatment Segment by Application
1.3.1 Global Graves Disease Treatment Market Value by Application: (2023-2029)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.4 Global Graves Disease Treatment Market Size Estimates and Forecasts
1.4.1 Global Graves Disease Treatment Revenue 2018-2029
1.4.2 Global Graves Disease Treatment Sales 2018-2029
1.4.3 Global Graves Disease Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Graves Disease Treatment Market Competition by Manufacturers
2.1 Global Graves Disease Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Graves Disease Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Graves Disease Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Graves Disease Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Graves Disease Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Graves Disease Treatment, Product Type & Application
2.7 Graves Disease Treatment Market Competitive Situation and Trends
2.7.1 Graves Disease Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Graves Disease Treatment Players Market Share by Revenue
2.7.3 Global Graves Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Graves Disease Treatment Retrospective Market Scenario by Region
3.1 Global Graves Disease Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Graves Disease Treatment Global Graves Disease Treatment Sales by Region: 2018-2029
3.2.1 Global Graves Disease Treatment Sales by Region: 2018-2023
3.2.2 Global Graves Disease Treatment Sales by Region: 2024-2029
3.3 Global Graves Disease Treatment Global Graves Disease Treatment Revenue by Region: 2018-2029
3.3.1 Global Graves Disease Treatment Revenue by Region: 2018-2023
3.3.2 Global Graves Disease Treatment Revenue by Region: 2024-2029
3.4 North America Graves Disease Treatment Market Facts & Figures by Country
3.4.1 North America Graves Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Graves Disease Treatment Sales by Country (2018-2029)
3.4.3 North America Graves Disease Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Graves Disease Treatment Market Facts & Figures by Country
3.5.1 Europe Graves Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Graves Disease Treatment Sales by Country (2018-2029)
3.5.3 Europe Graves Disease Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Graves Disease Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Graves Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Graves Disease Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Graves Disease Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Graves Disease Treatment Market Facts & Figures by Country
3.7.1 Latin America Graves Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Graves Disease Treatment Sales by Country (2018-2029)
3.7.3 Latin America Graves Disease Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Graves Disease Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Graves Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Graves Disease Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Graves Disease Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Graves Disease Treatment Sales by Type (2018-2029)
4.1.1 Global Graves Disease Treatment Sales by Type (2018-2023)
4.1.2 Global Graves Disease Treatment Sales by Type (2024-2029)
4.1.3 Global Graves Disease Treatment Sales Market Share by Type (2018-2029)
4.2 Global Graves Disease Treatment Revenue by Type (2018-2029)
4.2.1 Global Graves Disease Treatment Revenue by Type (2018-2023)
4.2.2 Global Graves Disease Treatment Revenue by Type (2024-2029)
4.2.3 Global Graves Disease Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Graves Disease Treatment Price by Type (2018-2029)
5 Segment by Application
5.1 Global Graves Disease Treatment Sales by Application (2018-2029)
5.1.1 Global Graves Disease Treatment Sales by Application (2018-2023)
5.1.2 Global Graves Disease Treatment Sales by Application (2024-2029)
5.1.3 Global Graves Disease Treatment Sales Market Share by Application (2018-2029)
5.2 Global Graves Disease Treatment Revenue by Application (2018-2029)
5.2.1 Global Graves Disease Treatment Revenue by Application (2018-2023)
5.2.2 Global Graves Disease Treatment Revenue by Application (2024-2029)
5.2.3 Global Graves Disease Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Graves Disease Treatment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Graves Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Graves Disease Treatment Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Merck & Co
6.2.1 Merck & Co Corporation Information
6.2.2 Merck & Co Description and Business Overview
6.2.3 Merck & Co Graves Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck & Co Graves Disease Treatment Product Portfolio
6.2.5 Merck & Co Recent Developments/Updates
6.3 Pfizer, Inc
6.3.1 Pfizer, Inc Corporation Information
6.3.2 Pfizer, Inc Description and Business Overview
6.3.3 Pfizer, Inc Graves Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer, Inc Graves Disease Treatment Product Portfolio
6.3.5 Pfizer, Inc Recent Developments/Updates
6.4 AbbVie, Inc
6.4.1 AbbVie, Inc Corporation Information
6.4.2 AbbVie, Inc Description and Business Overview
6.4.3 AbbVie, Inc Graves Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AbbVie, Inc Graves Disease Treatment Product Portfolio
6.4.5 AbbVie, Inc Recent Developments/Updates
6.5 Mylan N.V
6.5.1 Mylan N.V Corporation Information
6.5.2 Mylan N.V Description and Business Overview
6.5.3 Mylan N.V Graves Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mylan N.V Graves Disease Treatment Product Portfolio
6.5.5 Mylan N.V Recent Developments/Updates
6.6 Allergan, plc
6.6.1 Allergan, plc Corporation Information
6.6.2 Allergan, plc Description and Business Overview
6.6.3 Allergan, plc Graves Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Allergan, plc Graves Disease Treatment Product Portfolio
6.6.5 Allergan, plc Recent Developments/Updates
6.7 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Graves Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis AG Graves Disease Treatment Product Portfolio
6.7.5 Novartis AG Recent Developments/Updates
6.8 Apitope
6.8.1 Apitope Corporation Information
6.8.2 Apitope Description and Business Overview
6.8.3 Apitope Graves Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Apitope Graves Disease Treatment Product Portfolio
6.8.5 Apitope Recent Developments/Updates
6.9 Amgen INC.
6.9.1 Amgen INC. Corporation Information
6.9.2 Amgen INC. Description and Business Overview
6.9.3 Amgen INC. Graves Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Amgen INC. Graves Disease Treatment Product Portfolio
6.9.5 Amgen INC. Recent Developments/Updates
6.10 Sun Pharmaceuticals Industries LTD
6.10.1 Sun Pharmaceuticals Industries LTD Corporation Information
6.10.2 Sun Pharmaceuticals Industries LTD Description and Business Overview
6.10.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Portfolio
6.10.5 Sun Pharmaceuticals Industries LTD Recent Developments/Updates
6.11 Immunovant Inc
6.11.1 Immunovant Inc Corporation Information
6.11.2 Immunovant Inc Graves Disease Treatment Description and Business Overview
6.11.3 Immunovant Inc Graves Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Immunovant Inc Graves Disease Treatment Product Portfolio
6.11.5 Immunovant Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Graves Disease Treatment Industry Chain Analysis
7.2 Graves Disease Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Graves Disease Treatment Production Mode & Process
7.4 Graves Disease Treatment Sales and Marketing
7.4.1 Graves Disease Treatment Sales Channels
7.4.2 Graves Disease Treatment Distributors
7.5 Graves Disease Treatment Customers
8 Graves Disease Treatment Market Dynamics
8.1 Graves Disease Treatment Industry Trends
8.2 Graves Disease Treatment Market Drivers
8.3 Graves Disease Treatment Market Challenges
8.4 Graves Disease Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
